Possible teratogenic effect of phenothiazines in human beings.

A prospective survey was carried out by the French National Institute of Health and Medical Research (INSERM) in 12 University hospitals in Paris and included 12,764 women; 189 gave birth to babies with unequivocal, non-chromosomally based, malformations. There was a significant excess of malformed infants when women had taken phenothiazines during the first three months after the last menstrual period. This association did not seem due to chance or to bias and could not be explained by the influence of the outcome of previous pregnancies. These data are to be added to results of recent surveys showing a significant increase of malformations in children exposed in utero to anticonvulsants, carbamates, benzodiazepines, tricyclic antidepressants, and amphetamines.

[1]  M. Thaler,et al.  REYE'S SYNDROME , 1975, The Lancet.

[2]  G. Oakley,et al.  ASSOCIATION BETWEEN CLEFT LIP WITH OR WITHOUT CLEFT PALATE AND PRENATAL EXPOSURE TO DIAZEPAM , 1975, The Lancet.

[3]  D. Fleming,et al.  Letter: Fetal effects of tranquilizers in pregnancy. , 1975, The New England journal of medicine.

[4]  D. Miller,et al.  EXERCISE AND DIETARY-INDUCED THERMOGENESIS , 1975, The Lancet.

[5]  I. Saxén.  Associations between oral clefts and drugs taken during pregnancy. , 1975, International journal of epidemiology.

[6]  B. Clayton,et al.  A VARIANT OF PHENYLKETONURIA , 1975, The Lancet.

[7]  L. Milkovich,et al.  Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. , 1974, The New England journal of medicine.

[8]  S. Johansson,et al.  Letter: A radioimmunoassay for serum-alpha-fetoprotein based on commercial antisera. , 1974, Lancet.

[9]  S. Da.  Letter: Recruitment to mental handicap. , 1974 .

[10]  S. Shapiro,et al.  Diphenylhydantoin and selected congenital malformations. , 1973, The New England journal of medicine.

[11]  J. Fedrick.  Epilepsy and Pregnancy: A Report from the Oxford Record Linkage Study , 1973, British medical journal.

[12]  W. Wertelecki,et al.  Congenital malformation among offspring of epileptic women. , 1973, Lancet.

[13]  N. Nevin,et al.  Congenital malformations and anticonvulsant drugs. , 1973, Lancet.

[14]  C. Lowe.  CONGENITAL MALFORMATIONS AMONG INFANTS BORN TO EPILEPTIC WOMEN , 1973 .

[15]  J. South.  Teratogenic effect of anticonvulsants. , 1972, Lancet.

[16]  S. Meadow,et al.  Maternal epilepsy and abnormalities of the fetus and newborn. , 1972, Lancet.

[17]  H. Wiedemann,et al.  Drug usage and fetal development: preliminary evaluations of a prospective investigation. , 1972, Advances in experimental medicine and biology.

[18]  J. Levin.  Amphetamine ingestion with biliary atresia. , 1971, The Journal of pediatrics.

[19]  J. Forfar,et al.  Associations between Drugs Administered during Pregnancy and Congenital Abnormalities of the Fetus , 1971, British medical journal.

[20]  D. Mcnamara,et al.  Dexamphetamine: a possible environmental trigger in cardiovascular malformations. , 1970, The Lancet.

[21]  D. J. Vince.  Congenital malformations following phenothiazine administration during pregnancy. , 1969, Canadian Medical Association journal.

[22]  I. Schrire.  TRIFLUOPERAZINE AND FŒTAL ABNORMALITIES , 1963 .

[23]  A. J. Moriarity.  Trifluoperazine and Congenital Malformations. , 1963, Canadian Medical Association journal.

[24]  A. Blalock.  Surgical treatment of pulmonary stenosis. , 1947, Lancet.